Texas A&M researchers have developed drugs to enhance the function of nicotinic acetylcholine receptors. The drug can potentially have three very different applications: easing pain, slowing the cognitive decline and making it easier for people to stop smoking.
According to the scientists, the new drug acts on nicotinic acetylcholine receptors, which makes it possible to alleviate pain. Furthermore, it can slow the cognitive decline associated with neuropsychiatric diseases.
Another application of the drug is using it as a way to quit smoking. However, it involves activation of multiple nicotinic acetylcholine receptors, which can catalyse multiple side effects to occur.